CN102198152B - Injection containing astragalus polysaccharide-iron complex for swine, and preparation method thereof - Google Patents
Injection containing astragalus polysaccharide-iron complex for swine, and preparation method thereof Download PDFInfo
- Publication number
- CN102198152B CN102198152B CN 201110128690 CN201110128690A CN102198152B CN 102198152 B CN102198152 B CN 102198152B CN 201110128690 CN201110128690 CN 201110128690 CN 201110128690 A CN201110128690 A CN 201110128690A CN 102198152 B CN102198152 B CN 102198152B
- Authority
- CN
- China
- Prior art keywords
- solution
- astragalus polysaccharides
- ferrum
- injection
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001061264 Astragalus Species 0.000 title claims abstract description 88
- 235000006533 astragalus Nutrition 0.000 title claims abstract description 88
- 210000004233 talus Anatomy 0.000 title claims abstract description 88
- 238000002347 injection Methods 0.000 title claims abstract description 62
- 239000007924 injection Substances 0.000 title claims abstract description 62
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 229940078042 polysaccharide iron complex Drugs 0.000 title abstract 5
- 241000282898 Sus scrofa Species 0.000 title abstract 4
- 150000004676 glycans Chemical class 0.000 claims abstract description 83
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 82
- 239000005017 polysaccharide Substances 0.000 claims abstract description 82
- 150000002505 iron Chemical class 0.000 claims abstract description 40
- 238000000034 method Methods 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 91
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 84
- 239000007788 liquid Substances 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 239000012153 distilled water Substances 0.000 claims description 23
- 238000001914 filtration Methods 0.000 claims description 23
- 238000002604 ultrasonography Methods 0.000 claims description 23
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 22
- 239000000706 filtrate Substances 0.000 claims description 22
- VCJMYUPGQJHHFU-UHFFFAOYSA-N iron(3+);trinitrate Chemical compound [Fe+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O VCJMYUPGQJHHFU-UHFFFAOYSA-N 0.000 claims description 22
- 239000002244 precipitate Substances 0.000 claims description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 230000001476 alcoholic effect Effects 0.000 claims description 18
- 239000003480 eluent Substances 0.000 claims description 18
- 239000000284 extract Substances 0.000 claims description 18
- 239000003513 alkali Substances 0.000 claims description 15
- 239000000047 product Substances 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 15
- 239000009636 Huang Qi Substances 0.000 claims description 13
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 12
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 12
- 239000011347 resin Substances 0.000 claims description 12
- 229920005989 resin Polymers 0.000 claims description 12
- 238000005406 washing Methods 0.000 claims description 12
- 229910021578 Iron(III) chloride Inorganic materials 0.000 claims description 11
- 229960002413 ferric citrate Drugs 0.000 claims description 11
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical group Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 claims description 11
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 claims description 11
- 238000001291 vacuum drying Methods 0.000 claims description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- 238000010438 heat treatment Methods 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 10
- 239000012266 salt solution Substances 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 claims description 9
- DHCLVCXQIBBOPH-UHFFFAOYSA-N Glycerol 2-phosphate Chemical compound OCC(CO)OP(O)(O)=O DHCLVCXQIBBOPH-UHFFFAOYSA-N 0.000 claims description 9
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 claims description 9
- 229960004642 ferric ammonium citrate Drugs 0.000 claims description 9
- 229940046257 glyceryl phosphate Drugs 0.000 claims description 9
- 239000004313 iron ammonium citrate Substances 0.000 claims description 9
- 235000000011 iron ammonium citrate Nutrition 0.000 claims description 9
- PVFSDGKDKFSOTB-UHFFFAOYSA-K iron(3+);triacetate Chemical compound [Fe+3].CC([O-])=O.CC([O-])=O.CC([O-])=O PVFSDGKDKFSOTB-UHFFFAOYSA-K 0.000 claims description 9
- LHOWRPZTCLUDOI-UHFFFAOYSA-K iron(3+);triperchlorate Chemical compound [Fe+3].[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O LHOWRPZTCLUDOI-UHFFFAOYSA-K 0.000 claims description 9
- 230000000274 adsorptive effect Effects 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000002609 medium Substances 0.000 claims description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 5
- 238000010521 absorption reaction Methods 0.000 claims description 5
- 229910021529 ammonia Inorganic materials 0.000 claims description 5
- 238000012869 ethanol precipitation Methods 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 239000001509 sodium citrate Substances 0.000 claims description 5
- 241000894007 species Species 0.000 claims description 5
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 5
- 229940038773 trisodium citrate Drugs 0.000 claims description 5
- 239000008215 water for injection Substances 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 230000004083 survival effect Effects 0.000 abstract description 7
- 230000036039 immunity Effects 0.000 abstract description 3
- 235000016709 nutrition Nutrition 0.000 abstract description 3
- 241000282887 Suidae Species 0.000 abstract 2
- 239000004615 ingredient Substances 0.000 abstract 1
- 229910052742 iron Inorganic materials 0.000 description 11
- MVZXTUSAYBWAAM-UHFFFAOYSA-N iron;sulfuric acid Chemical compound [Fe].OS(O)(=O)=O MVZXTUSAYBWAAM-UHFFFAOYSA-N 0.000 description 11
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- 239000013589 supplement Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 241001071864 Lethrinus laticaudis Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229920002307 Dextran Polymers 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- -1 hydroxy ferrum Chemical compound 0.000 description 3
- 206010025482 malaise Diseases 0.000 description 3
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 2
- 231100000111 LD50 Toxicity 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- 238000010255 intramuscular injection Methods 0.000 description 2
- 239000007927 intramuscular injection Substances 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241001533384 Circovirus Species 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 206010034107 Pasteurella infections Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000505673 Scintilla Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- QRSFFHRCBYCWBS-UHFFFAOYSA-N [O].[O] Chemical compound [O].[O] QRSFFHRCBYCWBS-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010241 blood sampling Methods 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229960004887 ferric hydroxide Drugs 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- IEECXTSVVFWGSE-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide Chemical compound [OH-].[O-2].[Fe+3] IEECXTSVVFWGSE-UHFFFAOYSA-M 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 201000005115 pasteurellosis Diseases 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 150000004804 polysaccharides Polymers 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 208000009305 pseudorabies Diseases 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000000273 veterinary drug Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 208000024877 white muscle disease Diseases 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110128690 CN102198152B (en) | 2011-05-18 | 2011-05-18 | Injection containing astragalus polysaccharide-iron complex for swine, and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201110128690 CN102198152B (en) | 2011-05-18 | 2011-05-18 | Injection containing astragalus polysaccharide-iron complex for swine, and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102198152A CN102198152A (en) | 2011-09-28 |
CN102198152B true CN102198152B (en) | 2013-02-13 |
Family
ID=44659308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201110128690 Active CN102198152B (en) | 2011-05-18 | 2011-05-18 | Injection containing astragalus polysaccharide-iron complex for swine, and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102198152B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102552307B (en) * | 2012-03-13 | 2013-04-10 | 郑州百瑞动物药业有限公司 | Compound astragalus polysaccharide injection used for pigs and preparation method thereof |
CN105456185A (en) * | 2015-12-16 | 2016-04-06 | 浙江大飞龙动物保健品有限公司 | Compound Astragalus polysaccharides injection and preparation method thereof |
CN105924535B (en) * | 2016-04-27 | 2018-10-26 | 广西农业职业技术学院 | A kind of preparation method of astragalus polyose iron |
CN106038591A (en) * | 2016-05-31 | 2016-10-26 | 田东县浙缘农业科技有限公司 | Pig injection liquid containing astragalus polysaccharide iron |
CN107213115A (en) * | 2017-07-01 | 2017-09-29 | 山东中牧兽药有限公司 | A kind of compound Radix Astragali polysaccharide injection |
CN107714720A (en) * | 2017-10-30 | 2018-02-23 | 兰州大学 | A kind of preparation method for the Radix Angelicae Sinensis astragalus polyose iron complexes for treating hypoferric anemia |
-
2011
- 2011-05-18 CN CN 201110128690 patent/CN102198152B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN102198152A (en) | 2011-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102198151B (en) | Bulk pharmaceutical of swine astragalus polyferose and preparation method thereof | |
CN102198152B (en) | Injection containing astragalus polysaccharide-iron complex for swine, and preparation method thereof | |
CN103040730A (en) | Iron sucrose injection and preparation method thereof | |
CN103864950B (en) | A kind of preparation method and applications of low molecule Porphyra haitanensis polysaccharide iron complexes | |
CN102210405B (en) | Astragalus-polyferose-containing premix for pigs and preparation method thereof | |
CN101270148A (en) | Preparation for high-purity laver phycoerythrin with one-step chromatography | |
CN106749729B (en) | A kind of Smilacina japonica polysaccharide and its preparation method and application | |
CN102277255A (en) | Lucid ganoderma-gingko yellow wine as well as preparation method and function thereof | |
CN105924535B (en) | A kind of preparation method of astragalus polyose iron | |
CN103989041B (en) | A kind of how bioactive functional food and preparation technology thereof | |
CN106038591A (en) | Pig injection liquid containing astragalus polysaccharide iron | |
CN103044571A (en) | Iron dextran bulk drug and preparation method thereof | |
CN103622979A (en) | Preparation method of iron sucrose bulk drug and injection | |
CN107915772B (en) | Novel sweet potato glycoprotein and sweet potato glycoprotein extract containing the same | |
CN103262923B (en) | Cool and refreshing Pu'er healthcare tea and preparation process thereof | |
CN104945532A (en) | Preparing method for gynura divaricata polysaccharide | |
Giordano et al. | Oxystarch as a gastro-intestinal sorbent in uremia | |
CN103720649A (en) | Method for preparing alanyl-glutamine injection | |
CN107400173A (en) | A kind of preparation method and applications of LBP-X chromic compound | |
CN104605120A (en) | Terminalia chebula retz. preserved fruit and preparation method thereof | |
CN112315902B (en) | Preparation method of iron sucrose injection with low content of volatile iron | |
CN103690607A (en) | Improvement method of compound glycyrrhiza oral solution production technology | |
CN101419198A (en) | Stachyose content rapid detecting technology | |
CN106478837B (en) | A kind of green algae polysaccharide iron complexes and preparation method thereof that can be used for animals and plants and mend iron | |
CN108164610A (en) | Qamgur polyoses extract and extracting method and the application in immune drug is prepared |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160617 Address after: 262405, South County Industrial Park, Changle County, Shandong Province Patentee after: Shandong Kai Hong Biological Technology Co., Ltd. Address before: 301709 West Road, Wuqing Development Zone, Tianjin, Quanzhou Patentee before: Tianjin Zhonggao Biotechnology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201118 Address after: 355 200 No. 22 Pengjialan, Zhuxia Village, Tai Lao Shan Town, Fuding City, Ningde City, Fujian Province Patentee after: Lin Zefeng Address before: 262405, South County Industrial Park, Changle County, Shandong Province Patentee before: SHANDONG QIHONG BIOTECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201126 Address after: Qidong City, Jiangsu province 226200 Nantong lvsigang Tianfen electric tools trade city comprehensive building Patentee after: QIDONG TIANFEN ELECTRIC TOOL TECHNOLOGY INNOVATION CENTER Address before: 355 200 No. 22 Pengjialan, Zhuxia Village, Tai Lao Shan Town, Fuding City, Ningde City, Fujian Province Patentee before: Lin Zefeng |
|
DD01 | Delivery of document by public notice | ||
DD01 | Delivery of document by public notice |
Addressee: Liang Weicheng Document name: Notice of conformity |